全文获取类型
收费全文 | 86225篇 |
免费 | 5573篇 |
国内免费 | 318篇 |
专业分类
耳鼻咽喉 | 1338篇 |
儿科学 | 3854篇 |
妇产科学 | 2875篇 |
基础医学 | 9826篇 |
口腔科学 | 3447篇 |
临床医学 | 7748篇 |
内科学 | 17702篇 |
皮肤病学 | 2371篇 |
神经病学 | 6876篇 |
特种医学 | 3023篇 |
外国民族医学 | 10篇 |
外科学 | 13615篇 |
综合类 | 1098篇 |
一般理论 | 47篇 |
预防医学 | 5849篇 |
眼科学 | 2038篇 |
药学 | 5331篇 |
4篇 | |
中国医学 | 568篇 |
肿瘤学 | 4496篇 |
出版年
2023年 | 738篇 |
2022年 | 930篇 |
2021年 | 1925篇 |
2020年 | 1334篇 |
2019年 | 1920篇 |
2018年 | 2986篇 |
2017年 | 2172篇 |
2016年 | 2389篇 |
2015年 | 2238篇 |
2014年 | 2836篇 |
2013年 | 4123篇 |
2012年 | 5968篇 |
2011年 | 6803篇 |
2010年 | 3476篇 |
2009年 | 2614篇 |
2008年 | 5274篇 |
2007年 | 5673篇 |
2006年 | 5384篇 |
2005年 | 5380篇 |
2004年 | 5276篇 |
2003年 | 4792篇 |
2002年 | 4375篇 |
2001年 | 2059篇 |
2000年 | 2081篇 |
1999年 | 1428篇 |
1998年 | 686篇 |
1997年 | 537篇 |
1996年 | 444篇 |
1995年 | 341篇 |
1994年 | 315篇 |
1993年 | 310篇 |
1992年 | 421篇 |
1991年 | 378篇 |
1990年 | 313篇 |
1989年 | 271篇 |
1988年 | 297篇 |
1987年 | 232篇 |
1986年 | 241篇 |
1985年 | 213篇 |
1984年 | 256篇 |
1983年 | 215篇 |
1982年 | 195篇 |
1981年 | 152篇 |
1980年 | 169篇 |
1979年 | 201篇 |
1978年 | 182篇 |
1977年 | 153篇 |
1975年 | 134篇 |
1974年 | 126篇 |
1973年 | 151篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.
62.
Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration. 总被引:2,自引:0,他引:2
Hakon H Sigurdsson Einar Stefánsson Elínborg Gudmundsdóttir Thór Eysteinsson Margrét Thorsteinsdóttir Thorsteinn Loftsson 《Journal of controlled release》2005,102(1):255-262
Due to limited aqueous solubility of dorzolamide at physiologic pH, the pH of Trusopt eye drops (cont. 2% dorzolamide) has to be kept at about 5.65, and to increase the topical bioavailability of the drug from Trusopt the contact time of the drug with the eye surface is increased by increasing the viscosity of the eye drops to 100 cps. This low pH and high viscosity can lead to local irritation. In this study, dorzolamide hydrochloride was formulated as 2% and 4% low viscosity solutions (viscosity 3 to 5 cps) containing randomly methylated beta-cyclodextrin at pH 7.45. These formulations were evaluated in rabbits. The animals were sacrificed at various time points after topical administration of the drug and the dorzolamide concentration determined in the different parts of the eye. Trusopt was used as a reference standard. The topical availability of dorzolamide from the cyclodextrin-containing eye drops appeared to be comparable to that from Trusopt and the drug reached retina and optic nerve to give measurable concentrations for at least 8 h after administration of the eye drops. 相似文献
63.
Eric Racine Marie-Josée Dion Christine A. C. Wijman Judy Illes Maarten G. Lansberg 《Neurocritical care》2009,11(3):345-352
Background
Advances in intensive care medicine have increased survival rates of patients with critical neurological conditions. The focus of prognostication for such patients is therefore shifting from predicting chances of survival to meaningful neurological recovery. This study assessed the variability in long-term outcome predictions among physicians and aimed to identify factors that may account for this variability. 相似文献64.
65.
Youness El harrech Hassan Jira Jaouad Chafiki Mohamed Ghadouane Ahmed Ameur Mohamed Abbar 《Actas urologicas espa?olas》2009,33(1):93-96
Nutcracker syndrome is caused by compression of the left renal vein between the aorta and the superior mesenteric artery where it passes in the fork formed at the bifurcation of these arteries. The phenomenon results in left renal venous hypertension. The syndrome is manifested by left flank and abdominal pain, with or without unilateral haematuria. The nutcracker syndrome has been treated in various ways. We report one case of the syndrome and discuss the place of surveillance in its management. 相似文献
66.
67.
68.
National Programme of Research in Human Reproduction S.K. Banerjee R. Baveja R.V. Bhatt A. Chatterjee S.D. Choudhury B. Coyaji A.D. Engineer M.P. Gogoi V. Hingorani K. Lal M. Kochhar U. Krishna P. Misra F.S. Philips R. Rajan P.C. Sen Gupta K. Zaveri S. Datey S. Gupta S. Mehta N.C. Saxena B.N. Saxena 《Contraception》1986,34(6):573-582
The return of fertility following discontinuation of norethisterone oenanthate (NET EN) 200 mg injectable contraceptive after use for a minimum period of six months or more was studied in 69 women who discontinued the method for planning pregnancy. Former users of copper intra-uterine device (CuT 200) were enrolled as a control group. Another 161 women who had discontinued NET EN due to other reasons (e.g. amenorrhoea, excessive bleeding or personal reasons) were also studied for return of fertility after ensuring that they were not using any other method of contraception and were exposed to the risk of pregnancy. The subjects from both groups were followed for a period of one year. The cumulative conception rates at one year were 72.5 and 83.6 per 100 subjects for ex-NET EN and ex-CuT 200 users who had discontinued the method for planning pregnancy and this difference was not statistically significant (P > 0.05). The median time for conception for ex-NET EN users was 7.8 months as compared to 3.7 months in ex-CuT 200 users but the cumulative conception rates at the end of one year show that future return of fertility in NET EN users does not appear to be adversely affected.
In 51 subjects who had discontinued NET EN due to amenorrhoea, the return of fertility was predictably slower and less. The return of fertility in subjects who discontinued NET EN for other reasons (e.g. excessive bleeding and other personal reasons) was similar to ex-NET EN and ex-CuT 200 users. 相似文献
69.
Pascale Jolliet Stéphane Nion Gwena?lle Allain-Veyrac L Tilloy-Fenart Dorothée Vanuxeem Vincent Berezowski Roméo Cecchelli 《Pharmacological research》2007,56(1):11-17
PURPOSE: The objective of the current study was to determine the ability of some antiemetic compounds to cross the blood-brain barrier (BBB) and thereby to determine possible side effects of compounds for the central nervous system (CNS). METHODS: We compared the brain penetration of some antiemetic compounds using an in vitro BBB model consisting in brain capillary endothelial cells co-cultured with primary rat glial cells. RESULTS: This study clearly demonstrated that the metopimazine metabolite, metopimazine acid, has a very low brain penetration, lower than metopimazine and even less than the other antiemetic compounds tested in this study. CONCLUSIONS: The poor brain penetration of metopimazine acid, metopimazine biodisponible form, seems very likely related to the clinically observed difference in therapeutic and safety profile. 相似文献
70.